Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma
Wei Deng(Wuhan University), Steven H. Lin(The University of Texas MD Anderson Cancer Center), Christopher L. Hallemeier(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), Karthik Gonuguntla(Mayo Clinic in Arizona), Krishan R. Jethwa(Mayo Clinic), Mariela Blum Murphy(The University of Texas MD Anderson Cancer Center), Zhongxing Liao(Thoracic Surgery Foundation), Harry H. Yoon(Mayo Clinic)
Cited by 2
Related Papers
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
|JAMA Oncology|2018|1.8k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Neuropeptide S
|Neuron|2004|516